Gout

Disease State Hub

Featured

Video
Video
09/26/2024

Monica Richey, MSN, ANP-BC/GNP

Monica Richey, MSN, ANP-BC/GNP
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses the clinical challenges and strategies in managing a patient with severe tophaceous gout and stage 3 chronic kidney disease, including urate-lowering...
09/26/2024
expert Q&A
expert Q&A
09/20/2024

Hyon K Choi, MD, DrPH

Hyon K Choi, MD, DrPH
In this expert Q&A, lead study author Hyon K. Choi, MD, DrPH, discusses his team's study examining the association between serum urate levels and the rate of recurrent gout flares among patients with a...
09/20/2024
Pop Quiz
Pop Quiz
09/05/2024
Up to 40% of individuals with IBD may experience extraintestinal manifestations of the disease. Are you familiar with the common extraintestinal manifestations among these patients? Take the pop quiz to...
09/05/2024

Interactive Features

Pop Quiz
Pop Quiz
09/05/2024
Up to 40% of individuals with IBD may experience extraintestinal manifestations of the disease. Are you familiar with the common extraintestinal manifestations among these patients? Take the pop quiz to...
09/05/2024
Pop quiz
Pop quiz
02/22/2024
Risk factors for pseudogout include older age, joint trauma, genetic disorder, mineral imbalances, an underactive thyroid gland, or an overactive parathyroid gland. Do you know which joint is most impacted...
02/22/2024
poll
poll
01/29/2024
What do you observe as the main reason for nonadherence to urate-lowering therapy among your patients? Let us know by taking this quick poll!
01/29/2024
Treatment
Treatment
07/16/2020
Recent research may suggest that a combination of personalized treatment plus education about gout results in better treatment adherence rates in the long term. Do you agree?
07/16/2020
Treatment
Treatment
06/01/2020
The American College of Rheumatology Guideline for the Management of Gout recommends urate-lowering therapy (ULT) as first-line therapy for patients with gout. Do you know which specific therapeutic agent...
06/01/2020

Clinical Insights

Video
Video
09/26/2024

Monica Richey, MSN, ANP-BC/GNP

Monica Richey, MSN, ANP-BC/GNP
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses the clinical challenges and strategies in managing a patient with severe tophaceous gout and stage 3 chronic kidney disease, including urate-lowering...
09/26/2024
expert Q&A
expert Q&A
09/20/2024

Hyon K Choi, MD, DrPH

Hyon K Choi, MD, DrPH
In this expert Q&A, lead study author Hyon K. Choi, MD, DrPH, discusses his team's study examining the association between serum urate levels and the rate of recurrent gout flares among patients with a...
09/20/2024
Video
Video
05/29/2024

James Matera, DO

James Matera, DO
In this video, James Matera, DO, discusses guidelines for managing patients with chronic gout vs acute gout, hyperuricemia, and the symptom burden and risk factors of gout. This is part two of a three-part...
05/29/2024
Video
robert terkeltaub headshot
Video
04/05/2024
In this video, Robert Terkeltaub, MD, gives an overview of the current standard of care in the treatment of individuals with gout.
04/05/2024
Video
Video
03/20/2024

Monica Richey, MSN, ANP-BC/GNP

Monica Richey, MSN, ANP-BC/GNP
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses the clinical challenges and strategies of managing a patient with acute gouty arthritis and chronic hyperuricemia, including the variant HLA-B*58:01...
03/20/2024